4D Molecular Therapeutics
FDMT
FDMT
56 hedge funds and large institutions have $400M invested in 4D Molecular Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $665M → $400M (-$265M)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
56
Holding in Top 10
2
Calls
–
Puts
$2K
Top Buyers
| 1 | +$23.5M | |
| 2 | +$15.5M | |
| 3 | +$10.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$7.52M |
| 5 |
BlackRock
New York
|
+$4.43M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$12.1M | |
| 3 | -$8.68M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$6.83M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$6.51M |